Andrea Lindsay Hodges, LLMSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 29991 Mitchell St Bldg 328, Selfridge Angb, MI 48045 Phone: 734-677-0070 |
News Archive
Emergent BioSolutions Inc. announced today that its Investigational New Drug (IND) application, to commence a Phase I clinical trial for its anthrax monoclonal antibody therapeutic, has cleared U.S. Food and Drug Administration (FDA) review. The Phase I study will evaluate the safety and pharmacokinetics of the company's fully human monoclonal antibody being developed as a parenteral post-exposure therapy for individuals who have symptoms of anthrax disease. In pre-clinical therapeutic studies, Emergent's monoclonal antibody was found to be effective.
VOA News examines how the recession will be a factor in U.S. funding decisions about PEPFAR and other global health initiatives. According to VOA, the Obama administration's proposed funding for HIV, tuberculosis and malaria in 2010 is "higher than the current fiscal year. However, the proposed increase is lower than in some years past."
Scientists at The Scripps Research Institute have discovered that DNA stays too tightly wound in certain brain cells of schizophrenic subjects. The findings suggest that drugs already in development for other diseases might eventually offer hope as a treatment for schizophrenia and related conditions in the elderly.
Many scientists dream of making a single discovery that provides fundamental insight into nature, may be used to help save human lives, and can assist in the preservation of an endangered species. In new research reported in the journal Cell, a Japanese team is on the verge of accomplishing this nearly impossible feat.
The state will become the first to use a legislative vote to legalize physician-assisted suicide after the governor, who has expressed his support for the measure, signs the bill.
› Verified 8 days ago